Re-Imagining Drug Safety Powered by Genomics, Information Integration and Emerging Technologies

|| Whitepaper by Tata Consultancy Services. Pub. 17/08/2017 Abstract Scientific advancements, emerging technologies, and extensive information have created new opportunities for modernizing drug safety.  Simultaneously, the pharmacovigilance regulatory landscape is shifting to ensure improved safety for patients. This is the time to reimagine the  drug safety sector to transform it into an advanced, proactive and patient-centric practice. Introduction The global …

Adis

Adis launches services to support pharmacovigilance departments

Adis Pharmacovigilance will help pharmacovigilance teams to face the challenges of regulatory literature monitoring. Under the name of Adis Pharmacovigilance, Adis, a leading global provider of drug information, has launched an expanded range of services to support pharmacovigilance departments. This new suite of services includes monitoring special situation Individual Case Safety Reports (ICSRs), local literature and customised source coverage, ongoing …

Q2 2016 Cloud

Q2 Pharmacovigilance and Drug Safety Conferences – What did you miss?

Q2 Pharmacovigilance and Drug Safety Conferences – What did you miss? Great industry conferences are often the result of a combination of factors: good planning, strong speakers, with real depth in expertise and a passion for their topic, and attendees/delegates with great questions.  When all three line up in one event, all participants gain tremendous value from the presentations and …

The Rapidly Changing Paradigm for Pharmacovigilance

At last year’s World Drug Safety Congress Europe 2014 event, Vikram Dev, VP, Patient Safety, AstraZeneca, gave the presentation “The Rapidly Changing Paradigm for Pharmacovigilance.” Download and learn: Current PV information flow and safety profile assessment The EU Public Health Challenge Safety is everybody’s business Pharmacovigilance to focus on organ specific work Opportunities for growth Genomic medicine The toil of perfecting …

Pharmacovigilance Compliance strategies

At the World Drug Safety Congress Europe 2014 event, Noha Kassem, Senior Director, Quality and Head of the European Regional Centre, gave a presentation on “Pharmacovigilance Compliance strategies.” Download and learn: Pharmacovigilance Quality System Quality System Objectives Compliance in Pharmacovigilance Role of Quality Scope of Monitoring and Oversight Internal Audits Tiers of Oversight Download Presentation Found this interesting? You might …

Ebook: Your essential guide on trends, regulations and new technologies in Drug Safety

Drug safety must continue to evolve to meet heightened patient expectations and the fluctuating regulatory climate. It is becoming critical to exploit opportunities offered by emerging technologies, big data and personalised healthcare. To succeed in this new environment, we need to assess the regulatory updates; we need to examine how to implement regulations strategically and operationally in addition to discussing …

Embracing big data and emerging technologies in drug safety

Which new approaches are pharma companies taking to exploit opportunities offered by big data? We’ll be answering this question and many more as we discuss big data and related innovative technologies at World Drug Safety Congress Europe. Hear from a plethora of thought leaders who will be sharing real life examples of how to develop big data programmes and social media …

Addressing the key challenges for drug safety professionals

The regulatory environment is fast changing and the drug safety industry is facing significant hurdles in implementing standards globally. It is becoming increasingly challenging to meet all regulatory requirements effectively in the current globalised marketplace. Stay on top of pharmacovigilance requirements with updates directly from the regulators, agencies and industry who will show you how to implement regulatory standards globally. Learn …

Press release: World Drug Safety Conference hears call for wider use of cognitive safety testing in drug development

April 30, 2015 In a call to the pharmaceutical industry at the World Drug Safety Conference in Chicago last week (April 22 to 23), a leading developer of cognitive assessment software, Cambridge Cognition plc (Cambridge, UK; LSE AIM: COG), stressed the increasing regulatory and clinical need to expand cognitive safety testing beyond CNS-targeted drugs. Speaking to an international audience of …